Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ · Healthcare
Citius Pharmaceuticals, Inc. Net Income 2011–2022
Citius Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2011 to 2014. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Citius Pharmaceuticals, Inc. net income for the quarter ending June 30, 2014 was -34880, a 687.00% increase year-over-year.
- Citius Pharmaceuticals, Inc. net income for the twelve months ending June 30, 2014 was -664005, a 2484.18% increase year-over-year.
- Citius Pharmaceuticals, Inc. annual net income for 2022 was -33.6 M, a 45.92% increase from 2021.
- Citius Pharmaceuticals, Inc. annual net income for 2021 was -23.1 M, a 31.38% increase from 2020.
- Citius Pharmaceuticals, Inc. annual net income for 2020 was -17.5 M, a 12.76% increase from 2019.
- Citius Pharmaceuticals, Inc. annual net income for 2019 was -15.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Citius Pharmaceuticals, Inc. Net Income — FAQ
Citius Pharmaceuticals, Inc. (CTXR) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Citius Pharmaceuticals, Inc.'s net income?
Citius Pharmaceuticals, Inc. (CTXR) reported net income of -$34M for fiscal 2022.
Where can I see CTXR's net income history?
The chart and table above show Citius Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.